Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation is a research paper published in Bioorganic & Medicinal Chemistry (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R21 NS109687
National Institute of Neurological Disorders and Stroke
Grant: R01NS105787
NIAID NIH HHS
Grant: P30 AI117970
NIMHD NIH HHS
Grant: U54 MD007597
District of Columbia Developmental Center for AIDS Research
Grant: AI117970
National Institute of Neurological Disorders and Stroke
Grant: R01NS100947
NINDS NIH HHS
Grant: R21 NS133895
Howard University
National Institutes of Health
National Institute of Neurological Disorders and Stroke
MeSH Terms
Keywords